Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Compliance for genetic screening in the Arab population in Israel.

Sukenik-Halevy R, Leil-Zoabi UA, Peled-Perez L, Zlotogora J, Allon-Shalev S.

Isr Med Assoc J. 2012 Sep;14(9):538-42.

2.

Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.

Clayton EW, Hannig VL, Pfotenhauer JP, Parker RA, Campbell PW 3rd, Phillips JA 3rd.

Am J Hum Genet. 1996 Mar;58(3):617-27.

3.

Screening of CFTR mutations in an isolated population: identification of carriers and patients.

Chiba-Falek O, Nissim-Rafinia M, Argaman Z, Genem A, Moran I, Kerem E, Kerem B.

Eur J Hum Genet. 1998 Mar-Apr;6(2):181-4.

4.

Utilization of prenatal genetic testing by Israeli Moslem women: a national survey.

Sher C, Romano-Zelekha O, Green MS, Shohat T.

Clin Genet. 2004 Apr;65(4):278-83.

PMID:
15025719
5.

"It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.

Archibald AD, Jaques AM, Wake S, Collins VR, Cohen J, Metcalfe SA.

Am J Med Genet A. 2009 Dec;149A(12):2731-8. doi: 10.1002/ajmg.a.33122.

PMID:
19938084
6.
7.

Is cystic fibrosis carrier screening cost effective?

Wei S, Quigg MH, Monaghan KG.

Community Genet. 2007;10(2):103-9.

PMID:
17380060
8.

[Evaluation of utilization of preventive services for infants in Israel--personal and organizational determinants].

Palti H, Gofin R, Adler B.

Harefuah. 2004 Mar;143(3):184-8, 247. Hebrew.

PMID:
15065355
9.

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.

Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB.

Pediatrics. 2004 Jun;113(6):1573-81.

PMID:
15173476
10.

Large-scale population screening for spinal muscular atrophy: clinical implications.

Ben-Shachar S, Orr-Urtreger A, Bardugo E, Shomrat R, Yaron Y.

Genet Med. 2011 Feb;13(2):110-4. doi: 10.1097/GIM.0b013e3182017c05.

PMID:
21233719
11.

Cystic fibrosis carrier population screening in the primary care setting.

Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian HH Jr, Rowley PT.

Am J Hum Genet. 1996 Jul;59(1):234-47.

12.

Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.

Massie J, Forbes R, Dusart D, Bankier A, Delatycki MB.

J Paediatr Child Health. 2007 Nov;43(11):721-3.

PMID:
17924936
13.

Colorectal cancer among Arab-Israeli women--possible reasons for increased incidence and mortality.

Rainis T, Halloun L, Keren D, Shuv-ami I, Lavy A.

J Gastrointest Cancer. 2010 Jun;41(2):130-4. doi: 10.1007/s12029-009-9128-1.

PMID:
20108055
14.

Cystic Fibrosis testing among Arab-Americans.

Wei S, Feldman GL, Monaghan KG.

Genet Med. 2006 Apr;8(4):255-8.

PMID:
16617247
15.

Pediatricians' attitudes toward expanding newborn screening.

Acharya K, Ackerman PD, Ross LF.

Pediatrics. 2005 Oct;116(4):e476-84.

PMID:
16199673
16.

Prenatal testing for genetic disorders among Arabs.

Zlotogora J, Reshef N.

Prenat Diagn. 1998 Mar;18(3):219-24.

PMID:
9556038
17.

Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing.

Baker VL, Rone HM, Adamson GD.

Fertil Steril. 2008 Dec;90(6):2091-8. doi: 10.1016/j.fertnstert.2007.10.069. Epub 2008 Feb 4.

PMID:
18249390
18.

Cystic fibrosis mutations in Israeli Arab patients.

Laufer-Cahana A, Lerer I, Sagi M, Rachmilewitz-Minei T, Zamir C, Rivlin JR, Abeliovich D.

Hum Mutat. 1999 Dec;14(6):543.

PMID:
10571955
19.

Factors influencing health insurers' decisions to cover new genetic technologies.

Schoonmaker MM, Bernhardt BA, Holtzman NA.

Int J Technol Assess Health Care. 2000 Winter;16(1):178-89.

PMID:
10815363
20.

Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process.

Surh LC, Cappelli M, MacDonald NE, Mettler G, Dales RE.

Arch Pediatr Adolesc Med. 1994 Jun;148(6):632-7.

PMID:
8193692

Supplemental Content

Support Center